Table 3.
Demographic characteristics, risk factors and reported symptoms at onset of the prospective study
| Variables in the Prospective study | TB cases N = 14 | % | Non TB cases N = 71 | % | P value |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 5 | 35.7 | 39 | 54.9 | 0.2 |
| Female | 9 | 64.3 | 32 | 45.1 | |
| Age (in years) Mean ± (SD) | 9.6 ± 5.7 | 5.9 ± 4.5 | 0.01 | ||
| RISK FACTORS/ANAMNESTIC DATA/SYMPTOMS | |||||
| Fever ≥ 10 days | 1 | 7.1 | 29 | 40.8 | 0.02 |
| Cough ≥ 10 days | 3 | 21.4 | 48 | 67.6 | 0.002 |
| -chest pain | 1 | 33.3 | 11 | 22.9 | 0.6 |
| -hemoptysis | 0 | 0.0 | 1 | 2.1 | 0.9 |
| Asthenia | 7 | 50.0 | 43 | 60.0 | 0.5 |
| Weight loss | 3 | 21.4 | 14 | 19.7 | 0.9 |
| Lymphadenopathy | 6 | 42.9 | 11 | 15.5 | 0.03 |
| Night sweats | 0 | 0.0 | 24 | 33.8 | 0.008 |
| History of contact | 7 | 50.0 | 5 | 7.0 | < 0.001 |
| Travel in high risk countries | 1 | 7.1 | 7 | 9.9 | 0.8 |
| Antibiotic therapy | 3 | 21.4 | 49 | 69.0 | 0.002 |
| - no benefit | 3 | 100 | 38 | 77.5 | 0.3 |
| Born in high risk country | 2 | 14.3 | 5 | 7.1 | 0.4 |
| Immunosuppression or immunosuppressive therapy | 0 | 0.0 | 0 | 0.0 | - |
TB tubercolosis, SD Standard Deviation